Both the systemic and the intracerebral infusion of IL-2/Hsp70-treated NK cells led to the shrinking of the tumor to almost undetectable levels 8 days after treatment (p = 0.0029 and p = 0.0319, respectively), while non-activated NK cells were ineffective [164]. This evidence concerns the gene IL2 and neoplasm.